Small methodological point on immortal time bias: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Immortal time bias in a claims-database study posts 31–35
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters.
I would want the raw data before agreeing with my own summary of it.
Post #31 is the version of this I will quote in future. One addition.
Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.
Where I part company with post #32, and it is a narrow parting.
Having read the whole immortal time bias thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one instead.
This topic was referenced in
- Critiquing an observational claim about a class effect — one year onEvidence › Study critique · 9 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Critiquing an observational claim about a class effect
Posting this under the heading it deserves: Critiquing an observational claim about a class effect Everything below is what sits behind that. I was wrong about critiquing an observational claim in a thread…
|
2 | 6.9k | 14mo | |
|
A well-designed study with a badly written abstract
Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Reading back through what has been written here about well-designed…
|
+117 | 128 | 7.2k | 14mo |
|
Confounding by indication, explained with a concrete example
On the subject in the title: Confounding by indication, explained with a concrete example Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-2 ( N Engl J Med ,…
|
+21 | 25 | 21k | 11mo |
|
A claim built entirely on a subgroup analysis
A claim built entirely on a subgroup analysis Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with the settled view on claim built, and I…
|
+71 | 80 | 1.1k | 14mo |
|
A structured critique template this community uses — a second dataset
On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion. Posting a small dataset on structured critique template. It is mine,…
|
+47 | 51 | 16k | 15h |
Related topics — sharing the tags risk of bias, observational data, disputed
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Journal club: STEP-HFpEF and symptom endpoints — a second dataset
On the subject in the title: Journal club: STEP-HFpEF and symptom endpoints — a second dataset Working notes rather than a conclusion. Posting a small dataset on step-hfpef and symptom endpoints. It is mine,…
|
+11 | 15 | 4k | 10mo |
|
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Posting a small dataset on STEP 8. It is…
|
+18 | 22 | 656 | 13h |
|
Follow-up: A supplier that answers analytical questions with restated claims
A supplier that answers analytical questions with restated claims — setting out what I have, and where I think it stops being reliable. A follow-up question about supplier that I did not know to ask the first…
|
+74 | 82 | 2.8k | 6mo |
|
Journal club: semaglutide in MASH, and surrogate endpoints
Posting this under the heading it deserves: Journal club: semaglutide in MASH, and surrogate endpoints Everything below is what sits behind that. Working notes on semaglutide in MASH rather than a conclusion.…
|
+24 | 28 | 17k | 15h |
|
When a preprint is the best available evidence and we say so
When a preprint is the best available evidence and we say so — that is the question, and I have not found it answered plainly anywhere I have looked. A preprint question rather than a question about the…
|
+148 | 160 | 31k | 11mo |